is old creep
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Will Hillary really give Sam away?
Before or after we spin out of orbit 4/8/24?
Just replicate your London Server Login Bot in an endless loop then run it on random university mainframes and pass it on.
Nuthin showing below cept fer dat ol' $0.25 2013 daylight and da 2006 $69.99 gap above.
MedMen's 2nd restructuring is underway. Some stores are already being reopened under new management with former employees being offered their jobs back. No insolvency proceedings have been initiated. Licenses are being renewed. Stock is in suspended animation until SEC filings can be properly amended retroactively and brought up to date currently. After that, management will reapply for OTCQX listing. Until then, current stock holders have the choice of waiting it out or dumping for nothing to harvest tax losses. The fat lady isn't singing MedMen denouement at this time.
I have an old habit of staying up late reading chit after having me head handed to me on a platter coz, "learn from your mistakes", yah know?
Anyway, 20 years or so ago Scottrade made me money executing my orders then started playing games. I found an accountant blog that published a piece called Deep Capture where he goes so deep into the law and history of the markets that it becomes quite clear where we are today. People incapable of following the details call it "conspiracy theory" but after reading all the exceptions in the law clearly spelled out and justified by the notion preventing systemic failure, you'll realize it's "Conspiracy Reality". IMA card carrying conspiracy realist and I'll stop just as soon as conspirators stop being so obvious. Here's a good book on the subject https://www.deepcapture.com/introduction-to-the-deep-capture-analysis/
Sorry the accountants original has been obscured by so much E clutter that I couldn't find it. But one outstanding example is from when Bernie Madeoff was head of the SEC before he was busted for the ponzi scheme called the Madeoff exception which put a %limit on the number of retail shorts allowed on any given issue which applied to every issue traded except any issue Bernie Madeoff personally took a short position. That law is still on the book today.
WeHo just reopened fully stocked
Own Your Own
Own Your Own
Own Your Own
Own Your Own
Own Your Own
MedMen Franchise
Naked shorts, FTD's, exist. It's a systemic financial market issue allowed to be perpetuated precisely because it's a systemic issue for which there's no solution beyond a total market collapse so when a BD is short on a OTC issue when push comes to shove, they short other issues to cover. Game Stop was a short squeezing of retail hedge fund shorts who were forced to buy back the shares they shorted. Things like dividend distributions, or symbol changes that force a reconciliation of existing shares squeeze the BD's, and MM's carrying FTD's. I've seen BD's that don't pass on disclosures as required when they're carrying a lot of FTD's. Remember Scottrade? They be gone because of that. Unfortunately, the problem is just sold to the next guy. However, in the case of the FMCC nickel award we should watch for signs of distribution chicanery.
Yah, the Shark Tank Real Estate Tycoon just swore off investing in New York forever and has not made a secret of the reason being distrust of Government.
My FMCC shares are in multiple accounts so I got multiple lawsuit notices. To me that means I've got real shares. However, should I get receive the award in one account but not the other then there will be a new lawsuit.
No volume = retail selling dried up. Retail cannot buy. Only credited investors, BD's and shorts can buy or cover now. The company chose not to go the lower tier alternative reporting route so who would sell unless they want to offset gains? Come back during loss harvest season to see volume if the company hasn't caught up its fins before then or begins insolvency proceedings. The company's currently restructuring to reduce debt..
That's my FMCC common nickel right there. When will they be cutting the checks?
When did articles stop talking about the C-ship elephant in the room as if it's invisible?
ROFLMFAO!
Bradford will never allow the cramdown to go kaput. Do you have any idea how many dimes he's collected writing SA articles on the subject? His clout has yet to come out and when it does there will be furious thunder above (SPS) with feverish boot licking below (JPS). Then the restructuring of commons to oblivion will wipe out the whimpering common class coz, BRADFORD!
MMNFF Suspended Animation
Butinski no miss dat. Butinski say Fed want FnF subsidiary of Fed. Fed want Gooberment FnF positions, JPS positions, and Common positions. Fed no like competition. FnF competition.
Me no Previously. Me Butinski, Mongo's cousin Google stock sale proceeds loading FnF say Rumor.
Fork'em
Then we wait some more...
MedMen Announces Management and Board Changes
January 24, 2024 05:08 PM Eastern Standard Time
BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board effective today.
ABOUT MEDMEN:
MedMen (CSE: MMEN, OTCMKTS: MMNFF) is a premier American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Massachusetts, and New York, MedMen is known for its leading MedMen® and LuxLyte® brands offering cannabis in consumer-preferred product forms for medical and recreational use. MedMen produces and curates the best consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs. For more information please visit www.medmen.com.
He'll be back when volume breaks 50 Mily on its way to 100
All John has to do is identify as Jane checking the diversity box and viola!
Provided by Dow Jones
Jan 24, 2024 5:50 AM PST
By Steve Gelsi
Once hailed as the first cannabis unicorn, MedMen's fortunes have gone up in smoke
MedMen Enterprises Inc.'s stock has drawn a cease-trade order as the once high-flying cannabis company has dropped from a $3 billion valuation in 2018 to near zero.
Back in 2018 when California's recreational pot market was gearing up, MedMen Enterprises (MMNFF) opened its flagship store in Midtown Manhattan's upscale 5th Avenue to sell medical cannabis and hyped it as the Apple Store of Weed.
Its stock hit an all-time closing high of $6.94 on Oct 16, 2018, with a market cap of $3 billion.
On Jan. 12, the stock fell to $0.0006, a tiny fraction of a penny.
MedMen was notified on Jan. 11 by the OTC Markets Group Inc. that the company's shares have been moved to the OTC Expert Market from the OTCQB market because it has yet to file a 2023 annual report or a 10-Q for the quarter ending Sept 30, the company said in a filing
MedMen said it intends to reapply to the OTCQB once it files the reports with the Securities and Exchange Commission, according to the filing.
The OTC currently has a warning message attached to MedMen stock due to its current status as eligible for unsolicited quotes only.
On Jan. 5, the British Columbia Securities Commission and the Ontario Securities Commission issued a cease-trade order on MedMen's listing on the Canadian Securities Exchange, due to a lack of financial filing
MedMen said on Dec. 21 it did not know when it would complete the filings.
MarketWatch did not immediately receive a reply from MedMen to an email seeking comment.
In a May filing, MedMen listed total liabilities of about $573 million, and a shareholder deficit of about $357 million.
Its net loss for the three months ended March 25 increased to $31.5 million from $29.8 million in the year-ago quarter, as revenue fell to $27.2 million from $35.3 million in the year-ago period.
MedMen has been selling assets to raise cash.
MedMen said on Jan. 12 that it agreed to sell its non-core business operations in Arizona and assets in Nevada for a minimum of $24 million of cash, plus $5.5 million in short-term seller notes.
MedMen in July named former Acreage Holdings Inc. (ACRHF) and Hain Celestial Group Inc. (HAIN) executive Ellen Deutsch as its new chief executive.
The company's latest difficulties come in the face of strong competition from the illicit market in California, a slower-than-expected rollout of the New York market and other challenges.
But problems started surfacing six years ago when the stock was at its height.
After being founded in 2010 and quickly growing in California and other markets, Los Angeles-based MedMen failed in 2018 in its bid to acquire PharmaCann in a $682 million all-stock deal.
Meanwhile, one of its co-founders, Adam Bierman, left the company in 2020 in a move that sparked a flurry of legal actions. In December of 2022, Bierman won a $3.1 million arbitration settlement with MedMen.
Other problems arose when Ascend Wellness Inc. (AAWH) backed out of a deal to buy MedMen's New York business in 2022 in a move to preserve $70 million in cash
Also read: MedMen puts New York business on selling block after Ascend scraps deal
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
Take it to da Bank
Apparently I was misinformed Hanky Panky and Munchkin sucked Gold Sachs azz.
Who's da Party Pooper?
No tax? No HotDog 🌭 4 U!
Nope
So we're in conservatorship coz Hanky Panky's a lousy liars poker player?
The OTC took issue with MedMen's lack of timely financial reporting.
The OTC Marketplace Exchange knocked MedMen Enterprises Inc. (OTC: MMNFF) down a notch. The beleaguered cannabis company that at one time claimed to have a billion-dollar valuation is now getting a double-black diamond rating on the OTC.
If you are a skier, you know that double black diamond runs are for advanced skiers and come with risks of injury. On the OTC, it is called the Expert Market.
Restricted Quotes
In the case of MedMen, the Expert Market means that stock quotes are restricted from public viewing.
“OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting,” the OTC said.
Expert Market quotes are distributed only to broker-dealers, institutions, and accredited investors.
“All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making,” the OTC added.
Lack of Reporting
The main issue the exchange has with MedMen appears to be its failure to stay current on its reporting obligations.
In December, MedMen provided an update, saying: “In addition to the late filing of the Required Filings, as a result of the Required Filings anticipated to not being completed by November 29, 2023, the company does not believe it will be in a position to file its interim financial statements, management’s discussion and analysis and related certifications for the three-month period ended September 30, 2023.”
The company’s chief financial officer assumed that role just six months ago, after the departure of the previous CFO.
The company said that it has auditors working on the statements, but can’t tell investors when they will be ready. MedMen also told investors that it hadn’t taken any steps toward insolvency proceedings. However, the company has been selling off assets.
MedMen said in November that its fiscal year 2022 reports contained misstatements and errors and needed to be corrected. MedMen applied for a management cease trade order under National Policy 12-203 – Management Cease Trade Orders (NP 12-203), which was issued on Nov. 1, 2023, by the British Columbia Securities Commission.
Another was issued on Jan. 5, with the BCSC saying these were the financial documents that needed updating:
Interim financial report for the period ended Sept. 30, 2023
Annual audited financial statements for the year ended July 1, 2023
Management’s discussion and analysis for the periods ended July 1, 2023, and Sept. 30, 2023
Certification of annual and interim filings for the periods ended July 1, 2023, and Sept. 30, 2023.
Penny Lane
MedMen is a true penny stock as the shares are selling for one cent. Back in 2018, the stock sold for more than $6 a share.
At one time, MedMen was strutting its stuff – calling itself the Apple of cannabis – but then it got mired in scandal as the founders found themselves tossed from the company. There were multiple lawsuits, but MedMen had a streak of winning its lawsuits no matter had salacious the details were.
The company’s lender Gotham Green continues to own most of the company’s debt, and according to a filing on SEDAR, owns 30% of the Class B shares. Gotham Green as of October 2023, increased its ownership of Class B shares by 2.4% from July 2023.
Gotham Green could be making these moves to take over the company if it goes belly up.
https://www.greenmarketreport.com/medmen-downgraded-on-otc-marketplace/
SPS don't actually exist.
Why It makes perfect sense for Gooberment to Reverse Split their 79.9% collateral by 500 to 1 coz they'll hold 0.1598% afterward and whoever came up with that plan ought to run for President
Common upside with warrant dilution is still far above JPS ceiling. If Warrants are dissolved, commons will slap Elon Musk on the back of his head on their way to Jupiter.
Bizarre article considering it completely ignores shareholder rights are currently zero. So MSM has suddenly become the Twins' cheerleaders? There's something going wrong around here
But it's still a lot of fun to dress'em up in funny shirts and shorts.
After yah roll this up and smoke it, https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173523113
it's as clear as mud
They have ta refinance the mortgage again. My best guess